Fulcrum Therapeutics 10% owner Kevin Tang acquires $594,132 of common shares
FULC•Kevin Tang discloses common stock purchases
Tang Capital’s Kevin Tang, a 10% owner, disclosed purchases of Fulcrum Therapeutics common stock at $3.52 to $3.56 a share.
Beneficial ownership rose to 7,080,945 shares, held indirectly through Tang Capital-managed entities.
